Your search returned 78 studies. (Get alerts for new studies):
- Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (
Conditions: Non-Small Cell Lung Cancer
6 Locations available
- Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
Conditions: Leukemia
33 Locations available
- Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-
Conditions: Squamous Cell Lung Cancer
66 Locations available
- Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma - Stage IV Renal Cell Cancer
1 Location available
- A Study of CAL-101 and Rituximab in Elderly Patients With Untreated CLL or SLL
Conditions: Chronic Lymphocytic Leukemia (CLL) - Small Lymphocytic Lymphoma (SLL)
4 Locations available
- Study of Bevacizumab/mFOLFOX6 Versus Bevacizumab/Folfiri With Biomarker Stratification in Patients With Previously Untreated Metastatic Colorectal Can
Conditions: Colorectal Cancer
13 Locations available
- Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors
Conditions: Brain and Central Nervous System Tumors - Extragonadal Germ Cell Tumor - Ovarian Cancer - Teratoma - Testicular Germ Cell Tumor
2 Locations available
- Hyper-CVAD Plus Nelarabine in Untreated T-ALL/Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoblastic Lymphoma - Leukemia, Lymphoblastic, Acute
1 Location available
- Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia - CLL - Untreated - Front-line - First-Line - Initial Therapy
4 Locations available
- Induction Therapy-Docetaxel, Cisplatin and Fluorouracil in Untreated Advanced Squamous Cell or Undifferentiated Carcinoma of the Paranasal Sinuses
Conditions: Paranasal Sinuses - Squamous Cell Carcinoma
1 Location available
- Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia - Contiguous Stage II Small Lymphocytic Lymphoma - Noncontiguous Stage II Small Lymphocytic Lymphoma - Stage I Chronic Lymphocytic Leukemia - Stage I Small Lymphocytic Lymphoma - Stage II Chronic Lymphocytic Leukemia -
2 Locations available
- Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Conditions: Carcinoma of Unknown Primary
176 Locations available
- A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chro
Conditions: Chronic Lymphocytic Leukemia
6 Locations available
- Paclitaxel, Carboplatin and Cetuximab (PCC) Versus Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Loca
Conditions: Head and Neck Squamous Cell Carcinoma
2 Locations available
- Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma
Conditions: Sarcoma
5 Locations available
- Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
7 Locations available
- Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia
Conditions: Stage I Chronic Lymphocytic Leukemia - Stage II Chronic Lymphocytic Leukemia - Stage III Chronic Lymphocytic Leukemia - Stage IV Chronic Lymphocytic Leukemia
1 Location available
- Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloid
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
1 Location available
- Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma
Conditions: Lymphoma
1 Location available
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
149 Locations available
- Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin Lymphoma
Conditions: Lymphoma
2 Locations available
- A Study of Paclitaxel/Carboplatin With or Without IMC-3G3 in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Conditions: Non-Small Cell Lung Cancer
21 Locations available
- Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma
1 Location available
- Bendamustine and Rituximab Followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma
Conditions: Lymphoma, Follicular
1 Location available
- Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or
Conditions: Cognitive/Functional Effects - Fatigue - Lymphoma - Neurotoxicity - Therapy-related Toxicity
2 Locations available
- Trial of Low-Dose MTX and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma
Conditions: Follicular Lymphoma
1 Location available
- Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma - B Chronic Lymphocytic Leukemia
2 Locations available
- Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer
Conditions: Stage IV Pancreatic Cancer
2 Locations available
- Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus
Conditions: Hepatitis C, Genotype 1
6 Locations available
- Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Conditions: Haemophilia - Haemophilia A
8 Locations available
- Etoposide and Cisplatin in Treating Young Patients With Previously Untreated High-Risk Neuroblastoma Undergoing High-Dose Chemotherapy, Stem Cell Tran
Conditions: Neuroblastoma
2 Locations available
- Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer
Conditions: Small Cell Lung Cancer
17 Locations available
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
401 Locations available
- SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Hematopoietic/Lymphoid Cancer - B-cell Chronic Lymphocytic Leukemia - Contiguous Stage II Small Lymphocytic Lymphoma - Noncontiguous Stage II Small Lymphocytic Lymphoma - Stage 0 Chronic Lymphocytic Leukemia - Stage I Chronic Lymphocytic Leukemia - Stage
4 Locations available
- Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma
4 Locations available
- Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
Conditions: Burkitt Lymphoma - Diffuse Large B-cell Lymphoma, c-MYC Positive
5 Locations available
- Bendamustine Hydrochloride and Idarubicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) - Adult Acute Myeloid Leukemia With t(16;16)
1 Location available
- First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade
Conditions: Multiple Myeloma
1 Location available
- Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer - No Prior Chemotherapy
1 Location available
- Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
1 Location available
- Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
Conditions: Non Hodgkin's Lymphoma
1 Location available
- Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Conditions: Metastatic Pancreatic Cancer
23 Locations available
- Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
Conditions: Lymphoma
13 Locations available
- A Study of GA101 (RO5072759) in Combination With Chemotherapy in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia
10 Locations available
- Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma
29 Locations available
- Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma - Adult Lymphocyte Predominant Hodgkin Lymphoma - Adult Mixed Cellularity Hodgkin Lymphoma - Adult Nodular Sclerosis Hodgkin Lymphoma - Stage II Adult Hodgkin Lymphoma - Stage III Adult Hodgkin Lymphoma - Stage
1 Location available
- Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial
Conditions: Brain and Central Nervous System Tumors
143 Locations available
- Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma
Conditions: Lymphoma
21 Locations available
- Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
113 Locations available
- Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia
Conditions: Hematopoietic/Lymphoid Cancer - Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Myelodysplastic Syndromes - Recurrent Adult Acute Myeloid Leukemia - Secondary Myelodysplastic Syndromes - Untreated Adult Acute Myeloid Leukemia
2 Locations available
- Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
Conditions: Lymphoma
21 Locations available
- Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Conditions: Diffuse Large B-Cell Lymphoma - Lymphoma, Diffuse Large-Cell - Diffuse Large-Cell Lymphoma - Lymphoma
7 Locations available
- A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
15 Locations available
- A Trial of TBL-12 Sea Cucumber Extract in Patients With Untreated Asymptomatic Myeloma
Conditions: Myeloma
1 Location available
- Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency
Conditions: Multiple Myeloma - Renal Insufficiency
1 Location available
- Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma
Conditions: Mantle Cell Lymphoma
1 Location available
- Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma
Conditions: Lymphoma
1 Location available
- Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With CLL
Conditions: Chronic Lymphocytic Leukemia
6 Locations available
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
176 Locations available
- Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
2 Locations available
- Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse La
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lympho
Conditions: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
68 Locations available
- 5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Adult Acute Myeloid Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Recurrent Adult Acute Myeloid Leukemia - Secondary Acute Myeloid Leukemia - Secondary Myelodysplastic Syndromes - Untreated Adult Acute Myelo
1 Location available
- Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With Previously Untreated HIV-Related Diffuse Large B-Cell Non-Hodgkin Lym
Conditions: Lymphoma - Nonneoplastic Condition
13 Locations available
- E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and
Conditions: Advanced or Metastatic Solid Tumors - Previously Untreated Gastric Cancer
2 Locations available
- Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
Conditions: Metastatic Pancreatic Adenocarcinoma
5 Locations available
- A Study Comparing RO5072759 (GA101) 1000 mg Versus 2000 mg in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Conditions: Lymphocytic Leukemia, Chronic
5 Locations available
- A Study of RO5072759 (GA101) in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma, B-Cell
3 Locations available
- LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer
Conditions: Pancreatic Cancer
2 Locations available
- Linaglitpin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2
16 Locations available
- Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
1 Location available
- AZD2171 in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Conditions: Leukemia - Myelodysplastic Syndromes
6 Locations available
- Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma
Conditions: Follicular Lymphoma
1 Location available
- Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
2 Locations available
- A Phase II Study of Ofatumumab-Based Induction Chemoimmunotheraphy Followed by Consolidation Ofatumumab Immunotherapy in Previously Untreated Patients
Conditions: Small Lymphocytic Lymphoma - CLL (Chronic Lymphocytic Leukemia)
1 Location available
- Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma
Conditions: Non Hodgkin's Lymphoma
1 Location available
|